Jefferies & Co Downgrades Bio-Reference Labs (BRLI) to Hold
More News related to BRLI
- Bio-Reference Laboratories, Inc. Again Awarded New York State Department of Corrections Laboratory Services Contract
- SmallCapSentinel.com: Records and Revenues
- BioReference Laboratories, Inc to Speak at the Oppenheimer 20th Annual Health Care Conference
- Practice Fusion and BioReference Laboratories Team to Offer Free Electronic Health Records to Physicians
- BioReference Laboratories, Inc to Speak at the UBS Global Life Sciences Conference
More News related to Downgrades
- Mexican Restaurants (CASA) Posts Q3 Loss of $0.07, Better Y/Y; Revs Down
- Cosi (COSI) Posts Q3 Loss of $0.06, Beats By 2c
- Enterprise GP Holdings (EPE) Posts Q3 EPS of $0.18, Misses Views
- Mindray Medical (MR) Tops Q3 EPS by 6c; Revs Light
- Neenah Paper (NP) Tops Q3 Views
Jefferies & Co downgrades Bio-Reference Labs (Nasdaq: BRLI) from Buy to Hold.
To see more analyst ratings on BRLI Click Here.
Bio-Reference Laboratories, Inc. (Bio-Reference) is principally engaged in providing clinical laboratory testing services, primarily to customers in the greater New York metropolitan area, as well as to customers in a number of other states.
Related Categories
DowngradesStocks Mentioned
+0.38Related Entities
Comments
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
BRLI
HWK on Jul 6, 2009 12:17 PMI wish all the limp "wrists" would sell their 1 and 2,000 shares of this stock and let it get on with it's growth! This company can only go one way, that of being acquired. It's a lovely little thing, but too small to survive in this pond. It's going to go for mid to high $40's, no question.....